With online health and wellness company Hims & Hers opening a new front in the GLP-1 compounding showdown Thursday, the ...

FDA Commissioner Dr. Marty Makary spoke exclusively with "Good Morning America" about updating guidelines for the "no ...

Novo Nordisk has also spoken out strongly against Hims & Hers' compounded Wegovy pill, with CEO Maziar Mike Doustdar telling ...

New federal guidelines are set to make it easier for shoppers to understand what’s really in their food.

On Super Bowl Sunday, the drug industry is trotting out lounging football stars, a shouting DJ Khaled, and the soothing tones ...

By Carlos Méndez and Chris Thomas Feb 5 (Reuters) - The U.S. Food and Drug Administration (FDA) will take swift action ...

Hims & Hers Health said Saturday that it would no longer offer a compounded pill version of the popular weight-loss medicine Wegovy, following increased scrutiny from federal regulators.Hims announced ...

The FDA is poised to take action against companies marketing unauthorized drugs as equivalents to FDA-approved products. Hims ...

The U.S. FDA plans to act against companies marketing illegal copycat drugs. Commissioner Marty Makary's remarks follow Hims and Hers Health's introduction of a cheaper, non-FDA-approved version of ...

Hims & Hers (HIMS) stock drops as FDA warns against illegal copycat drugs while Novo (NVO) threatens action over the ...

A Democratic lawmaker is raising new concerns about a Food and Drug Administration program designed to drastically shorten ...